In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key win in Delaware. With a Thursday ruling (PDF) from Delaware’s highest court ...
The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...
The FDA has approved a reformulated version of ranitidine tablets that includes new storage conditions to address previous safety concerns regarding impurity formation. The Food and Drug ...
The U.S. Court of Appeals for the Eleventh Circuit heard oral arguments on Friday about whether to reverse a 2022 ruling tossing the plaintiffs’ experts in thousands of Zantac lawsuits. ‘I don’t think ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback